ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,089Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 168

$825K Total Retail Price of All Prescriptions

Rank: 5 out of 168

534 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 534 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

16% of this provider’s 534 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 9,045 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $114 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
FUROSEMIDE 561 455 1 2
SIMVASTATIN 491 428 2 8
LEVOTHYROXINE SODIUM 440 351 3 15
HYDROCODONE-ACETAMINOPHEN 401 230 S3 4 18
OMEPRAZOLE 360 247 5 12
DOXAZOSIN MESYLATE 296 262 6 21
AMLODIPINE BESYLATE 287 216 7 1
CALCITRIOL 252 239 8 6
ALLOPURINOL 227 193 9 13
CARVEDILOL 219 194 10 11
METOPROLOL SUCCINATE 210 182 11 16
LISINOPRIL 195 172 12 3
METOPROLOL TARTRATE 192 160 13 7
ATORVASTATIN CALCIUM 191 131 14 19
METFORMIN HCL 183 127 15 29
GABAPENTIN 167 102 16 26
ATENOLOL 157 111 17 38
LOSARTAN POTASSIUM 138 106 18 10
GLIMEPIRIDE 133 123 19 44
LISINOPRIL-HYDROCHLOROTHIAZIDE 131 97 20 82
GLIPIZIDE ER 128 92 21 77
LOSARTAN-HYDROCHLOROTHIAZIDE 126 110 22 53
CRESTOR 125 106 23 41
CLONIDINE HCL 119 90 24 9
RENVELA 116 69 25 4
WARFARIN SODIUM 114 96 26 31
INSULIN SYRINGE 112 85 27 42
GLIPIZIDE 101 87 28 45
LANTUS 101 63 28 37
FINASTERIDE 100 88 30 61
NIFEDIPINE ER 99 80 31 28
TRAMADOL HCL 96 78 32 35
PRAVASTATIN SODIUM 93 74 33 27
HUMULIN N 84 63 34 66
BYETTA 84 67 34 140
OXYCODONE HCL 80 54 S2 36 83
ROPINIROLE HCL 80 50 36 71
SERTRALINE HCL 79 45 38 52
ZOLPIDEM TARTRATE 79 54 38 40
COLCRYS 78 64 40 76
PREDNISONE 76 62 41 23
TAMSULOSIN HCL 75 59 42 36
HYDROCHLOROTHIAZIDE 71 47 43 20
AMITRIPTYLINE HCL 71 36 R 43 62
SPIRONOLACTONE 70 60 45 25
METFORMIN HCL ER 70 54 45 64
NEXIUM 68 68 47 43
GLIPIZIDE XL 67 59 48 119
POTASSIUM CHLORIDE 67 52 48 30
POLYETHYLENE GLYCOL 3350 67 46 48 108
CIPROFLOXACIN HCL 66 48 51 63
ENALAPRIL MALEATE 65 29 52 32
LANTUS SOLOSTAR 64 47 53 95
PEN NEEDLE 63 45 54 105
JANUVIA 61 36 55 46
PANTOPRAZOLE SODIUM 61 29 55 39
ZETIA 60 35 57 68
TOPIRAMATE 59 24 58 79
LEVOXYL 59 54 58 158
TERAZOSIN HCL 59 57 58 60
TRIAMTERENE-HCTZ 58 48 61 86
CITALOPRAM HBR 55 35 62 59
PROAIR HFA 55 21 62 69
DIOVAN 55 32 62 24
CLOPIDOGREL 55 45 62 78
KLOR-CON M20 53 39 66 56
SENSIPAR 52 17 67 5
AZITHROMYCIN 52 44 67 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 17, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.